David Nassif
Chief Executive Officer presso SIO GENE THERAPIES INC.
Profilo
David W.
Nassif is currently the CEO, CFO, Director, CAO & General Counsel at Sio Gene Therapies, Inc. He is also the Chief Financial Officer at Pharvaris NV.
Previously, he served as the Chief Financial Officer & Senior Vice President at Cypros Pharmaceutical Corp.
from 1993 to 1999.
He was also the Chief Financial Officer at Zaldiva, Inc. Additionally, he held the position of CFO, Secretary, Treasurer & Executive VP at Zogenix, Inc. in 2010.
From 2002 to 2006, he served as the Chief Financial Officer & SVP-Global Licensing at Amphastar Pharmaceuticals, Inc. He was the Chief Financial Officer & Senior Vice President at RealAge, Inc. from 2000 to 2001.
He worked as a Principal at Strategic Consulting Services from 2001 to 2002 and again in 2006.
From 2011 to 2014, he was the President & Chief Financial Officer at Histogen, Inc. He also served as the Chief Financial Officer & Executive Vice President at SteadyMed Ltd.
from 2013 to 2019.
In 2019, he briefly held the position of Chief Financial Officer at Axovant Sciences, Inc. Mr. Nassif obtained his undergraduate degree from the University of Virginia and his graduate degree from the University of Virginia School of Law.
Posizioni attive di David Nassif
| Società | Posizione | Inizio |
|---|---|---|
| SIO GENE THERAPIES INC. | Chief Executive Officer | 31/01/2022 |
| PHARVARIS N.V. | Director of Finance/CFO | 15/04/2024 |
Precedenti posizioni note di David Nassif
| Società | Posizione | Fine |
|---|---|---|
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Director of Finance/CFO | 01/12/2020 |
| STEADYMED LTD | Director of Finance/CFO | 30/06/2019 |
Histogen, Inc. /Old/
 Histogen, Inc. /Old/ Medical/Nursing ServicesHealth Services Histogen, Inc. is a regenerative medicine company. It focuses on developing patented technologies that replace and regenerates tissues in the body. The firm's applications include hair stimulating complex, matrix regeneration, and skin care. The company was founded in 2007 and is headquartered in San Diego, CA. | Director of Finance/CFO | 01/09/2014 |
| ZOGENIX, INC. | Director of Finance/CFO | 02/03/2010 |
| Strategic Consulting Services | Corporate Officer/Principal | 01/10/2006 |
Formazione di David Nassif
| University of Virginia | Undergraduate Degree |
| University of Virginia School of Law | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| AMPHASTAR PHARMACEUTICALS, INC. | Health Technology |
| PHARVARIS N.V. | Health Technology |
| Aziende private | 9 |
|---|---|
| Cypros Pharmaceutical Corp. | Health Technology |
Zaldiva, Inc.
 Zaldiva, Inc. Specialty StoresRetail Trade Zaldiva, Inc. engages in selling comic books, toys and collectible items. The company also sells graphic novels, collector supplies, action figures, toys, dolls, posters, t-shirts, trading cards and statues. Zaldiva's other products and services include discounted comic and magazine subscriptions, toys/statues pre-orders, lay-a-way, sideshow collectibles, gift cards, comic grading services and personal shopper services. The company was founded on August 11, 1997 and is headquartered in Fort Lauderdale, FL. | Retail Trade |
Zogenix, Inc.
 Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. | Health Technology |
RealAge, Inc.
 RealAge, Inc. Internet Software/ServicesTechnology Services RealAge, Inc. provides personalized health information and on-line personal health management tools. The company runs hospitals and clinics in different parts of the United States. It was founded by Charles Silver and Michael Roizen in 1996 and is located in San Diego, CA | Technology Services |
| Strategic Consulting Services | |
Histogen, Inc. /Old/
Histogen, Inc. /Old/ Medical/Nursing ServicesHealth Services Histogen, Inc. is a regenerative medicine company. It focuses on developing patented technologies that replace and regenerates tissues in the body. The firm's applications include hair stimulating complex, matrix regeneration, and skin care. The company was founded in 2007 and is headquartered in San Diego, CA. | Health Services |
SteadyMed Ltd.
 SteadyMed Ltd. Pharmaceuticals: MajorHealth Technology SteadyMed Ltd. was engaged in the research, development, and manufacture of pharmaceutical products through the PatchPump technology. Its portfolio included Trevyent for pulmonary arterial hypertension and At Home Patient Analgesia for post-surgical pains. The company was founded on June 15, 2005 and was headquartered in Rehovot, Israel. | Health Technology |
Sio Gene Therapies, Inc.
 Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company was founded on October 31, 2014 and is headquartered in New York, NY. | Health Technology |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Health Technology |
- Borsa valori
- Insiders
- David Nassif
